SHARES in pharmaceutical firm South African Druggists rose on Tuesday morning after Fedsure said last Friday that it is close to tying up a long-running bid to win SAD’s health care interests. Fedsure announced that it had sold its 34% majority shareholding in SAD to financial group Investec for R33 a share. Under the deal, Investec will sell the whole of SAD’s businesses to pharmaceutical group Aspen Healthcare Holdings for about R2,4-billion. Aspen will then sell on SAD’s health care business to Fedsure for R470-million and its Intramed and fine chemicals interests to Macmed Healthcare Ltd for R500-million.